
Improvements in technology have renewed interest in the technique.

Improvements in technology have renewed interest in the technique.

Reduced infection rate may drive increased use of the transperineal approach.

This article explores the current and potential future use of immunotherapy in prostate, kidney, and bladder cancer.

Published: December 22nd 2020 | Updated:

Published: April 11th 2019 | Updated:

Published: February 3rd 2020 | Updated: